The case against oesophageal resection

Annals of the Royal College of Surgeons of England

Volumn 89, Issue 6, 2007, Pages 586-588

  Barr, Hugh ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; OMEPRAZOLE; ANTIULCER AGENT;

ARGON PLASMA COAGULATION; ARTICLE; BARRETT ESOPHAGUS; CANCER INCIDENCE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DYSPLASIA; ENDOSCOPIC BIOPSY; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MORBIDITY; PHOTODYNAMIC THERAPY; QUALITY OF LIFE; SURGICAL MORTALITY; SURVIVAL RATE; ESOPHAGUS TUMOR; GASTROINTESTINAL ENDOSCOPY; METHODOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; PRECANCER; QUALITY ADJUSTED LIFE YEAR; REVIEW;

ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; OMEPRAZOLE; PHOTOCHEMOTHERAPY; PRECANCEROUS CONDITIONS; QUALITY-ADJUSTED LIFE YEARS;

EID: 34548627844     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588407X209248     Document Type: Article

References (12)

1. Cancer Research UK. UK Oesophageal Cancer Mortality Statistics. 2006 .
2. British Society of Gastroenterology. BSG guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. 2005 .
3. Garside R. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess 2006; 10: 1-158.
4. Bachmann MO, Alderson D, Edwards D, Wotton S, Bedford C, Peters TJ et al. Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers. Br J Surg 2002; 89: 914-22.
5. Zaninotto P, Parenti AR, Ruol A, Costantini M, Merigliano S, Ancona E. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 2000: 97: 1102-5.
6. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J et al. Reproducibility of the diagnosis of dysplasia in Barrett's oesophagus: a reaffirmation. Hum Pathol 2001; 32: 368-78.
7. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz AD, Connell S et al. Long term non-surgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-19.
8. Ormsby AH, Petras RE, Henricks WH, Rice TW, Rybicki LA, Richter JE et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002; 51: 671-6.
9. Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC et al. on behalf of the International Photodynamic group for High-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 2005; 62: 488-98.
10. Vij R, Triadafilopoulos G, Owens DK, Kunz P, Sanders GD. Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 2004; 60: 739-56.
11. Kelty CJ, Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MWR. Endoscopic ablation of Barrett's oesophagus: a randomised controlled trial of photodynamic therapy vs argon plasma coagulation. Br J Surg 2004; 91: 142.
12. Pech O, May A, Gossner L, Ell C. Barrett's esophagus: endoscopic resection. Gastrointest Endosc Clin North Am 2003; 13: 505-12.